H-1B sponsorship profile: Synnovation Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, Synnovation Therapeutics, Inc filed 2 Labor Condition Applications covering 2 H-1B worker positions between fiscal year 2024 and fiscal year 2024. The employer’s DOL certification rate sits at 100% (2 certified of 2 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Synnovation Therapeutics, Inc’s H-1B petitions range from $119,819 at the low end to $119,819 at the high end, with a petition-weighted average of $119,819. That range reflects the mix of occupations the company sponsors, led by Principal Research Investigator (2 petitions at $119,819 avg). H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Synnovation Therapeutics, Inc is headquartered in Wilmington, DE under NAICS code 54171, and places H-1B workers across 1 state, most heavily in DE. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Synnovation Therapeutics, Inc ranks. By H-1B petition volume, Synnovation Therapeutics, Inc is #48,558 of 119,880 employers nationally and #341 of 943 employers headquartered in DE. Both ranks are computed live from the same underlying petition counts, not a separate estimate.